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(W. Baumeister).The Role of Protein Aggregation in Neurodegeneration
Neurodegeneration is characterized by loss of function and death of neuronal cells, resulting in a
progressive deterioration and loss of connectivity of neuronal circuits. These neurodegenerative
processes lead to diverse syndromes like dementia, movement disorders (dystonia), and behav-
ioral abnormalities as an expression of the so far incurable and lethal neurological diseases:
Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic
lateral sclerosis (ALS), and other rare syndromes.
Despite massive research efforts, conclusive insights into the disease mechanisms are lacking.
An enormous number of >190 000 publications (PubMed search for MeSH Terms: ‘Alzheimers
disease’, ‘Parkinsons disease’, ‘Huntingtons disease’, and ‘Amyotrophic lateral sclerosis’ on
12 August 2020) is on record to date (AD: 93 000, PD: 66 000, HD: 12 000, ALS: 19 000), but
a solution to the problem of neurodegeneration is not yet in sight.
A common histopathological hallmark of many neurodegenerative diseases is the presence of
pathognomonic protein aggregates [1,2]. Aggregates may form due to mutations that render
disease-specific proteins aggregation-prone or increase their cellular concentration. Moreover,
environmental factors [3] and aging effects also play important roles. In particular, the cellular
proteostasis capacity strongly declines with age [1].
Although aggregates were first identified and associated with neurodegeneration by Alois
Alzheimer more than 110 years ago, their role in pathology remains controversial [4]. The
term ‘aggregate’ should be differentiated at this point, as there are at least two distinct states:
(i) small, soluble, oligomeric aggregates, which can develop into (ii) large insoluble protein
aggregates known as inclusion bodies (IBs; see Glossary), reported to adopt amyloidogenic
and amorphous conformations. The presence of small soluble oligomeric aggregates is strongly
associated with toxicity in many of these proteinopathies, including AD [5–7], PD [8], ALS [9], andTrends in Cell Biology, December 2020, Vol. 30, No. 12 https://doi.org/10.1016/j.tcb.2020.08.007 951
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Glossary
CLEM (Correlative Light and
Electron Microscopy): uses the
strength of both methods – the ability to
identify macromolecules by fluorescent
light microscopy and the molecular
resolution of electron microscopy to
correlate micrographs of the same
region of the sample.
Conventional electron microscopy:
uses a transmission microscope that
probes the sample with accelerated
electrons, which have a resolution limit
orders of magnitude better than visible
light. The liquid content of biological
matter is incompatible with the vacuum
of an electronmicroscope, thus samples
are chemically fixed, dehydrated, and
plastic embedded and furthermore
stained with heavy metals to increase
contrast.
Cryo-Electron Tomography (Cryo-
ET): a novel high-resolutionmethod that
is able to take 3D snapshots
(tomograms) of the molecular landscape
inside cells with an electron microscope.
The essential point of this method – to
keep the biological sample in its pristinely
preserved, close-to-native state – is
achieved by vitrification (cryo-
preservation), which keeps all proteins
and cellular structures in their original
conformation at a certain point in time.
Inclusion body (IB): a large protein
aggregate – pathognomonic for most
neurodegenerative diseases. They
contain the disease protein among
others and are found in the cytosol and/
or the nucleus. Their role in the disease
pathology is a major topic of debate.
Super-resolution light microscopy:
a group of light-microscopic techniques
that circumvent Abbe’s diffraction limit
and thus reach higher resolution. There
are two major branches of super-
resolution microscopy: deterministic and
stochastic approaches. These methods
rely on the fluorescent labeling of the
structure of interest.
Trends in Cell BiologyHD [10–17], and IB formation is often interpreted as a protective mechanism [2,18]. However, be-
sides oligomers, IBs may also play significant cytotoxic roles in these pathologies [4], as observed
for α-synuclein [8,19], Tau [20,21], TDP-43 [22,23], and amyloid beta [24]. IBs containing
α-synuclein are found in PD, Lewy-body disease, multisystem atrophy, and pure autonomic
failure [25]. Hyperphosphorylated tau protein precipitates cytosolically into neurofibrillary tangles
found in IBs of AD, fronto-temporal dementia, progressive supranuclear palsy, and several other
tauopathies [26]. TDP-43 accumulates in IBs found in ALS and fronto-temporal dementia but also
in Lewy-body disease, AD, PD, HD, Pick’s disease, progressive supranuclear palsy, and Guam
parkinsonism–dementia complex [27]. Amyloid beta is the main constituent of the extracellular
neuritic plaques found in AD and Down syndrome [28]. Although the IBs of the various neuro-
degenerative diseases are formed by different proteins, they typically consist of cross β-sheet
amyloid fibrils [29].
In this review, we will focus on protein aggregation in HD, which is a relatively rare disease
(5–7 cases per 100 000 persons [30]), but its etiology is a mutation in a single gene. Therefore,
studies onHD aremore directly comparable than those on AD, PD, and ALS, all with predominantly
sporadic and unclear etiologies. HD is caused by the expansion of a CAG repeat in the IT15 gene
that codes for the Huntingtin (Htt) protein, resulting in the expansion of a poly-glutamine (polyQ) re-
peat in the N terminus of this protein. In HD pathology, N terminal fragments of polyQ-expandedHtt
aggregate into oligomers and IBs [31]. The studies interpreting IBs as protective entities argue that
oligomers, as the more toxic species, are sequestered into less toxic IBs [10,13,32,33]. By con-
trast, other studies propose that IBs are toxic to cells and important for the disease mechanism
[34–36]. The toxicity of aggregates can be mediated either by loss- or gain-of-function effects
[1]. It has been shown that expanded polyQ canmisfold in vitro into different conformational states,
which may have different neurotoxicity in vivo [37,38]. Such structural diversity is indeed recapitu-
lated in the brains of HDmice, as amyloids in the striatum were associated with significantly higher
toxicity and had a conformation different from other brain regions [37]. This supramolecular poly-
morphism may be a more general phenomenon for disease-related amyloids [39–42].
To clarify the role of aggregates in disease, many recent studies investigated the structure of
aggregates in vitro at high resolution using fibrils either extracted from patients or generated
in vitro [43]. The investigation of neurodegeneration in living cells is restricted to cell cultures
and animal models, which can only partially recapitulate the disease phenotype [44,45]. To
gain comprehensive understanding of these diseases, it is important to develop new tools and
strategies to image patient-derived material. This will be discussed in the concluding remarks.
In this review, we focus on methods with subcellular resolution to investigate the structure of
IBs within their cellular environment: conventional electron microscopy (EM), super-
resolution (SR) light microscopy (LM), and cryo-electron tomography (cryo-ET).
Conventional Electron Microscopy
Transmission electron microscopy (TEM) has enabled the investigation of cells and tissues at the
nanoscale for about seven decades. Biological samples are intrinsically aqueous and thus not
compatible with the vacuum of the electron microscope. In conventional EM this problem is over-
come by chemical fixation, dehydration, and resin embedding of the cells or tissue. For contrast
enhancement, samples are stained with heavy metals. The target thickness for TEM investiga-
tions is limited to a few hundred nm. Biological samples are regularly much thicker and are thus
usually thinned down by microtome sectioning.
The first EM study of HD was published in 1997 and presented IBs in human brain (Figure 1A)
[34]: IBs were described as highly heterogenous and were found mainly in the cytosol of neurons952 Trends in Cell Biology, December 2020, Vol. 30, No. 12
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Trends in Cell Biologyof adult patients, while nuclear localization was more frequent in patients with juvenile onset of
HD. Cytosolic IBs were surrounded by organelles, mainly mitochondria, and not delimited by a
membrane. To deepen the understanding of the ultrastructural architecture of Htt IBs, several
studies further analyzed IBs in transgenic animal models [46–48] and transfected human cell
lines [49,50] by conventional EM (Figure 1B–F). Both nuclear and cytosolic IBs were found in
these model systems.
The visual appearance of the IBs was, however, heterogeneous between the different studies (see
Table S1 in the supplemental information online): several studies described the IBs as substantially
amorphous, containing granular and only a few fibrillar structures (Figure 1A–C) [34,46–48], while
others observed fibrils more clearly (Figure 1D,E) [49,50]. It is difficult to explain this variance by
the properties of the sample (Table S1), but it may be related to the sample preparation
procedures. As for any microscopic method, the quality of the sample preparation determines
the quality of the final image. Chemical fixation, dehydration, resin embedding, and staining with
heavy metals are procedures that likely induce structural artifacts [51], particularly at the molecular
level. The removal or substitution of water molecules inevitably denatures proteins through the loss
of the hydration shell and causes soluble cytoplasmic components to precipitate onto membranes
or fibrillar structures [52,53], leaving ‘empty’ white spaces in the micrographs. Thus, it is likely that
differences in sample preparation procedures may have substantially contributed to the
heterogeneity of IB ultrastructure in studies using conventional EM.
However, conventional EM allows analysis of patient-derived tissues and visualization of the
localization and distribution of cellular IBs [34]. Furthermore, conventional EM allows immunogold
labeling of structures to identify them in the plethora of structures in the cellular landscapes.
Another advantage of this method is the potential to cover a larger volume by imaging multiple
serial sections.
Light Microscopy
Individual amyloid fibrils are too small to be visualized by conventional LM. SR techniques (Box 1)
that work around Abbe’s diffraction limit have been great advances in modern fluorescenceFigure 1. Comparison of Htt IBs in Model Systems and Patients Imaged by Conventional Electron Microscopy
(EM). (A) Human neuronal intranuclear IB (hNII) in the cortex of a Huntigton’s disease (HD) patient immunolabeled with anti-
Htt antibody (Ab1). Upper: hNII in a cortical neuron appears as a dense aggregate with no limiting membrane separating i
from the nucleoplasm. Lower: higher magnification of hNII shows the presence of labeled granules and filaments within the
inclusion. Inset: serial section of hNII shows fibrils organized in random and parallel arrays. (B) Huntingtin within the
neuronal nucleus of transgenic R6 mice. Discrete deposition of Htt115-156Q exon 1 within two neuronal intranuclear IBs
(arrowheads) labeled by antibodies against huntingtin. (C) Intranuclear Htt51Q exon 1–15 IB of tgHD Sprague Dawley ra
labeled with EM48 antibody. Upper: a striatal neuron showing a round intranuclear IB (large arrow) slightly larger than the
neighboring nucleolus (N). Lower: at higher magnification, the membraneless IB reveals a granular and fibrilla
(arrowheads) appearance. (D) Transfected 293 Tet-Off cells containing Htt83Q exon 1 IB, after expression for 3–5 days
Upper: cell containing a typical perinuclear inclusion body. Lower: at higher magnification (part of area boxed in uppe
figure), Htt83Q exon 1 fibrils with a diameter of roughly 10 nm can be observed. (E) Huntingtin IBs. MCF-7 cells were
transiently transfected with an N terminal 969 amino acid long truncated, FLAG-tagged, 100Q Htt-construct (FH969–
100Q) and immunostained for FLAG using the immunoperoxidase method. Upper: this cell contains one Flag-labeled Ht
IB. Note the radiating fibrils in the core (C) and the less defined structure in the shell (S). Multilamellar-type autophagic
bodies (a) abut the shell. Lower: higher magnification of the IB (boxed area in upper figure). The broken line is the
approximate boundary between the shell (S), which is heavily labeled for Flag, and the core (C), which is not. There are
radiating fibrils in the core (arrows). (F) Ultrastructural transmission electron microscopy analysis of CAG53b stained
neuropil inclusion or dystrophic neurite (G) from the cortex of a Tet/HD94 mouse. Inset in (F) shows a 3.5× magnification
of the indicated area. Inset in (G) shows a 2.5× magnification of the indicated area. (A) modified, with permission, from
DiFiglia et al. [34]; (B) modified, with permission, from Davies et al. [46]; (C) modified, with permission, from Petrasch-
Parwez et al. [48]; (D) modified, with permission, from Waelter et al. [50]; (E) modified, with permission, from Qin et al. [49]
(F,G) modified, with permission, from Díaz-Hernández et al. [59].







Trends in Cell BiologyLM and offer the possibility to investigate dynamic cellular processes at resolutions below 100 nm
[54–56].
Super Resolution Methods
The mechanisms underlying Htt IB formation in the cell were studied by live-cell imaging using
structured illumination microscopy (SIM) (Figure 2A) [57]. At first, small aggregates clustered in
the cytosol chiefly by diffusion. Thus, in contrast to previous models, it was proposed that active
transport via microtubules is not an important initiator of IB growth. Aggregates not only fuse, but
can also undergo fragmentation (Figure 2B).
Cytosolic fibrillar aggregates of ~100 nm in diameter and ~1–2 μm in length were observed in
fixed neuronal-like differentiated PC12 cells (derived from a pheochromocytoma of the rat
adrenal medulla) using single-molecule active-control microscopy, besides the IBs and the
diffuse pool of monomers and oligomers (Figure 2C) [58]. Individual huntingtin fibrils have a
diameter of 8 nm [34,46,48–50,59–61] and therefore the aggregates observed in this study
likely correspond to fibril bundles and not to single fibrils. Later on, the authors used stimulated
emission depletion live-cell imaging to show that such large fibrillar Htt exon 1 aggregates
appear all over the cytosol after the initial aggregation of mutant Htt into IBs (Figure 2D) [62].
The fact that these fibrils appeared only in advanced growth stages of the IB was interpreted
as a probable failure of the cellular degradation system in preventing the nucleation of the
toxic aggregated protein species.
Another study examined the aggregation dynamics of IBs in living mouse ES-D3 cells (mouse
embryonic multipotent stem cells) and mouse STHdh striatal cells (mouse striatal cell line) byBox 1. Super-Resolution (SR) Light Microscopy (LM) Methods
SR-LM is a set of novel imaging techniques that circumvent the diffraction limit of light and reach a resolution down to well
below 100 nm. Two major groups of SR microscopy can be distinguished: stochastic and deterministic approaches. To
visualize the structure of interest, proteins need to be fluorescently labeled. Live-cell imaging is a big advantage of LM
methods; to increase precision, samples can also be fixed.
Structured illumination microscopy (SIM) [107] is a deterministic SR technique. Two laser beams interfere to create a stripe
pattern close to the resolution limit with which the sample is illuminated. The interference of the pattern frequency with high
frequency features of the sample are computationally decoded from the resulting images to reconstruct high resolution im-
ages. SIM can be used for live-cell imaging with high temporal (10–30 Hz) and spatial resolution (80–100 nm) with
conventional fluorophores and low phototoxicity. The imaging depth is sufficient for multilayered tissues.
Single-molecule active control microscopy (SMACM) [108], also often called single-molecule localization microscopy, is a
group of stochastic SR techniques, including photoactivated localization microscopy (PALM), fluorescence photo-
activation localization microscopy (F-PALM), super-resolution optical fluctuation imaging (SOFI), and stochastic optical
reconstruction microscopy (d)STORM, that have the advantage of reaching a particularly high resolution, down to
10–20 nm. This is achieved by fitting the point spread function to the image of isolated fluorophores. The localization
precision is only limited by the intensity of the emitter. Typically, the fluorophores of biological samples are too close to
each other to be detected individually. By activating stochastically only a sparse subset of emitters at a time, their
precise localization can be achieved. These methods are typically rather slow (minutes scale), compared with biological
time scales and thus less optimal for live-cell imaging. However fast-switching dyes [109] and scientific complementary
metal-oxide-semiconductor (sCMOS) cameras [110] allow live-cell imaging with subsecond frame rates. The imaging
depth is sufficient for single cells.
Stimulated emission depletion microscopy (STED) [111,112] is also a deterministic SR technique that utilizes two laser
pulses: an excitation beam superimposed with a depletion beam with an intensity minimum in the focal center that shapes
the effective scanning spot size by depletion of peripheral emitter fluorescence. STED reaches a spatial resolution around
40–50 nm, with frame rates in the tens of seconds scale. Phototoxicity needs to be considered due to high laser intensities.
The imaging depth is sufficient for multilayered tissues.
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Figure 2. Investigation of Huntingtin Inclusion Bodies (IBs) by Novel Light Microscopy (LM) Techniques. (A) High-speed structured illumination microscopy
(SIM) recordings of intracellular aggregate dynamics. All small aggregates are subjected to dramatic random movements, which lead to collisions and contacts among
clusters. Using a single particle tracking algorithm, individual particles were identified and their trajectories were analyzed in time at a frame rate of 5 Hz (right).
The velocity spectrum (left). Scale bar, 5 μm. (B) Poly-glutamine (PolyQ) aggregates undergo frequent fusion and fragmentation events in the cell. Aggregate motion
includes both active and passive transport components. The purple circles highlight regions where small clusters were identified in the automated analysis. The broken
(Figure legend continued at the bottom of the next page.)
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differentiated: (i) fast diffusion, (ii) dynamic clustering, and (iii) stable aggregation [63]. The results
provide insights into mutant Htt aggregate formation and how these structuresmay disrupt gene-
control mechanisms in neuronal cells. Large, stable aggregates in the nucleus form ’sticky’ decoy
traps that impair the function of key regulators of gene expression involved in neurological
disorders.
Other Light Microscopic Approaches
To monitor the aggregation properties of Htt exon 1 with different polyQ lengths in cells, Kim et al.
[12] applied a single molecule fluorescence fluctuation spectroscopy technique known as
numbers and brightness (N&B) [64] on Neuro2a cells expressing Htt exon 1 (Neuro2a cells derive
from a mouse neuroblastoma). The N&B method uses intensity fluctuations to estimate the
average number of fluorescent molecules per pixel and their oligomerization state (brightness).
With this method different aggregation states can be distinguished. Thereby the aggregation
process was followed over time from monomers and small oligomers (6–12 molecules), to large
oligomers (22–28 molecules), and eventually to macroscopic IBs (>2 μm). Interestingly, this analy-
sis showed that the formation of IBs did not substantially reduce the concentration of oligomers.
Using fluorescence recovery after photobleaching (FRAP), Peskett et al. [60] investigated the
nature of the signal intensity of bright and dim IBs formed by Htt exon 1 in Saccharomyces
cerevisiae and human embryonic kidney (HEK293) cells. FRAP uses a laser to bleach fluorescent
molecules in a defined volume; depending on the diffusivity/mobility of the fluorescent molecules
in this volume, the signal intensity may recover. The dim assemblies showed high internal mobility
and were thus considered liquid-like macroscopic structures, which gradually convert over time
into the brighter IBs that behaved like solids (Figure 2E). With conventional EM, the authors
confirmed that solid-like IBs were fibrillar, in contrast to the amorphous liquid-like IBs.
These studies show that SR-LM, but also advanced diffraction-limited fluorescent imaging, are
invaluable tools for the investigation of dynamic processes in living cells, in particular for the
study of the structural progression of protein aggregates in situ. However, as the resolution of
these methods is limited, they cannot fully clarify IB ultrastructure.
Cryo Electron Tomography
In contrast to conventional EM, cryo-ET is capable of imaging cellular structures at molecular
resolution while preserving the sample in an unperturbed, close-to-native state.
To prevent the water from evaporating in the microscope vacuum, physical fixation through very
rapid freezing (104–105 K/s) results in the formation of amorphous ice [65–67]. This process is called
vitrification and transforms liquid water into a glass-like solid, not allowing water molecules toorange and red rectangles indicate regions where fusion and fragmentation take place, respectively. Scale bar, 2 μm. (C) Small aggregate, imaged with super-resolution
(SR) microscopy, based on the light-induced blinking of single eYFP fused to Htt exon1. Upper: diffraction-limited (DL) image. Lower: SR reconstruction of the structure as
histograms of localizations. (D) Fibrillar structures Imaged by live-cell stimulated emission depletion microscopy (STED). Left: example of fibrillar structures coexisting with
inclusion bodies, imaged by live-cell SR STEDmicroscopy. Middle: outlines of identifiable linear fibril segments. Right: width distribution ofN = 207 individual cross-sections
of fibrils [full width at half maximum (FWHM) of Gaussian fit]. (E) Fluorescence recovery after photobleaching (FRAP) analysis of Htt exon1 inclusion bodies. Left: FRAP
experiment showing high Htt exon1 mobility in dim assemblies but not in bright assemblies. Scale bar, 3 μm. Right: averaged FRAP recovery curves. Shaded areas
represent 95% confidence intervals. (F) Numbers and brightness (N&B) analysis of cells expressing Q18, Q64, and Q150+ for 24 and/or 48 h. Left: the left images
show the pixel selection map of the analyzed cell, alongside the histograms of the number of pixels per molecular brightness. The green/red/blue curves indicate
monomers/6-12mers/22-28mers. Middle and right: characterization of cell populations in progressive stages of aggregation. The fraction of cells containing small
oligomers (red circles) and large oligomers (blue circles) were quantified using N&B; cells containing aggregates (gray circles) and inclusions (black circles) were
quantified using conventional LM. (A,B) modified, with permission, from Lu et al. [57]; (C) modified, with permission, from Sahl et al. [58]; (D) modified, with permission,
from Sahl et al. [62]; (E) modified, with permission, from Peskett et al. [60]; (F) modified, with permission, from Kim et al. [12].
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expansion and the exclusion of solvents. Vitrification preserves cellular samples in a close-to-native
state, fully hydrated, unstained, with halted Brownian motion. Molecular structures are well
preserved in their physiological state, shape, and conformation, allowing high resolution imaging.
Electron micrographs are 2D projections of the entire 3D object. Thus, features from different
layers are superimposed, making it difficult to interpret these images in their third dimension.
Cryo-ET provides 3D volumes of the sample, by computationally reconstructing many projection
images recorded by tilting the sample in the beam.
In the recent past, three major technological advances refined the cryo-ET methodology (Box 2)
and thereby made new ways of studying cellular processes possible: firstly, direct electron
detectors [68–70] increase the signal-to-noise ratio (SNR) and allow for correcting beam-induced
motion, which otherwise limits resolution. Secondly, the development of the cryo-focused ion
beam (cryo-FIB) technology, which opens windows into the interior of frozen-hydrated vitrified
cells by producing thin lamellas [71,72]. And finally, the development of the Volta-phase plate,
which enables imaging of the sample close to focus and with maximum contrast [73,74].
These technological advances make cryo-ET uniquely capable of investigating IBs in situ, in their
pristinely preserved cellular environment, at molecular resolution [75]. The first study dissectingBox 2. Workflow of Correlative Cryo-Electron Tomography (Cryo-ET)
The aim of cryo-ET is to visualize the unperturbed cellular landscape in its full complexity at molecular resolution [113].
Cellular processes, macromolecules, and their interactions, as well as pathological conditions, can be observed in their
native environment. The preservation of biological matter in a close-to-native state is achieved by vitrification: a very rapid
freezing of the sample (see main text), providing optimal structural conservation.
Targeting the Structure of Interest (Correlative Microscopy)
The large landscape of many hundreds to thousands of eukaryotic cells grown or deposited on an EM grid (Figure IA)
typically requires identification of cells containing the structure of interest (e.g., protein aggregates). Furthermore, localiza-
tion of subcellular features is challenging because the volume of a eukaryotic cell (several thousand μm3) is much larger
than the volume of a tomogram (around 1 μm3) (Figure IB) of the structure of interest.
Targeting the structure of interest can be achieved by fluorescently labeling the cellular feature and correlative light and
electron microscopy (CLEM) [114]: the vitrified cells are imaged by fluorescence cryo-LM and consecutively by cryo-
scanning electron microscopy (SEM). By superimposing (indicated by Σ) the images obtained by both microscopes
(Figure IA,B) the subcellular location of a structure of interest can be determined with a precision of about 200–300 nm
[115]. Recent approaches using SR-LM yield higher localization precision and combine the power of both methods: the
high resolution of cryo-ET and the ability to identify the visualized molecular species [116].
Opening Windows into the Cell (Lamella Preparation)
The main limitation of TEM is the sample thickness. Electrons interact strongly with matter, so that only biological samples
with a thickness of ≤500 nm can be imaged with sufficient signal-to-noise ratio (SNR), although thinner samples (around
200 nm) are preferable. As eukaryotic cells are typically much thicker, the region of interest needs to be thinned down
(Figure IC). In a cryo-FIB/SEM dual-beam instrument, a thin lamella, containing the structure of interest (Figure ID), is
prepared with a focused ion-beam from a single cell [71].
Tomography
The lamella containing the structure of interest is transferred into a cryo-TEM. A series of projections is acquired by tilting
the sample. These projections are computationally reconstructed into a 3D-representation of the sample: the tomogram.
The imaging electron-dose is limited in cryo-EM due to sample damage, thereby limiting the contrast and SNR. Two recent
developments, direct imaging detectors and the Volta-phase-plate, drastically increase both parameters. Recurrent struc-
tures in the tomogram can be averaged by sub-tomogram averaging [117,118] to improve SNR and resolution.
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Figure I. Workflow of Correlative Cryo-Electron Tomography (Images A–F: modified, with permission, from [91]).
Trends in Cell Biologypathological protein aggregation in situ used the aforementioned advanced cryo-ET methods to
investigate polyQ-expanded Htt exon1 IBs in their cellular environment of primary mouse neurons
and immortalized human cells [61].
IB Architecture and Ultrastructure
Primary mouse neurons and HeLa cells expressed GFP-tagged Htt Exon 1 (Htt97Q-GFP) and
were processed following the workflow presented in Box 2 to generate tomograms of the IBs.
Htt97Q-GFP inclusions, roughly spherical and ~3 μm in diameter, were mostly cytosolic
but also occasionally found in the nucleus. Both cytosolic and nuclear inclusions were formed
by mostly radially arranged amyloid-like fibrils with a diameter of 7–8 nm and a length of 100–
200 nm, yet neither granular nor amorphous material was observed (Figure 3A,B). Despite
the dense appearance of the IB network, the fibrils occupied less than 3% of the IB volume,
resembling a gel-like structure. On the contrary, the expression of a similar Htt Exon 1 construct
in S. cerevisiae led to the formation of amorphous IBs [76]. Thus, the morphology of Htt Exon1
aggregates varies in different cellular environments, possibly due to differences in the protein
quality control machineries [77,78]. These data show that cryo-ET can efficiently distinguish dif-
ferent IB architectures.
Images of vitrified biological matter reflect snapshots of the physiological condition. Thus, the
analysis of the curvature of fibrils provides insight into their mechanical properties (flexibility)Trends in Cell Biology, December 2020, Vol. 30, No. 12 959
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Figure 3. Cytosolic Inclusion Bodies (IBs) of Mutant Huntingtin Visualized by Cryo-Electron Tomography (Cryo-ET). (A) Tomographic slice of an IB
(Htt97Q-GFP inclusion body) in an Htt97Q-GFP-transfected mouse primary neuron. The cytoplasmic electron dense particles are ribosomes (white
arrowheads). (B) 3D rendering of the tomogram shown in (A). Endoplasmic reticulum (ER) membranes (red), Htt97Q-GFP fibrils (cyan), ribosomes (green),
vesicles (Vs) (white), and mitochondria (gold). Note that the core of the IB is largely devoid of ribosomes, which are abundant at the IB periphery. Scale
bars, 400 nm in (A) and (B). (C) High-magnification image of Htt97Q-GFP fibrils (red arrowheads) decorated by globular densities (green arrowheads). Scale
bar, 30 nm. (D) Magnified rendering of the region marked in (B) showing interaction sites (white circles) between Htt97Q-GFP fibrils and the ER membrane.
Scale bar, 50 nm. (E) Tomographic slice showing Htt97Q-GFP fibrils (red arrowheads) decorated by globular densities (green arrowheads) interacting with
cellular membranes in Htt97Q-GFP-transfected neurons. Scale bar, 100 nm. (F) 3D rendering of a vesicle trapped in an IB. Note the membrane-bound ribosome and the
high curvature of the vesicle membrane at the sites of interaction with fibrils. Scale bar, 100 nm. (A–F) modified, with permission from Bäuerlein et al. [61].
Trends in Cell Biologyat physiological temperature: the Htt fibrils persistence length (stiffness) was approximately
2.6 μm, in the range of actin and also Tau filaments [72,79].
The resolution in this study was high enough to identify globular densities decorating the fibrils.
These densities had a diameter of ~6 nm, consistent in size with GFP-dimers (Figure 3C). Control
analyses of Htt97Q IBs without a GFP tag revealed similar fibril diameter and length but without
the globular densities. In general, fibrils were always observed as part of inclusions, suggesting
that IBs are the main site of fibril growth in the cell [80]. However, since a tomogram covers
only a small percentage of the entire cell, isolated fibrils in other parts of the cell could have
been missed, as well as small fibrils (<50 nm) that cannot be reliably detected. The gel-like IB
core was largely devoid of large macromolecules such as ribosomes, which were abundant at
the IB periphery.960 Trends in Cell Biology, December 2020, Vol. 30, No. 12
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Strikingly, fibrils contacted membranes of organelles at the IB periphery (Figure 3D,E), including
mitochondria, lysosomes, and, most prominently, the endoplasmic reticulum (ER). At the sites
of contact, the impingement of fibrils caused high membrane curvature. Ribosome-free
ER-tubes often protruded into the IB, interacting extensively with the fibril network (Figure 3B,D).
Numerous irregular shaped vesicles were embedded in most cytosolic inclusions at sites of
interaction with organelles. Many of these vesicles were contacted by fibrils at regions of extreme
membrane curvature, suggesting that they resulted from fibril-mediated disruption of organelles.
Some of these trapped vesicles carried ribosomes (Figure 3F), suggesting that they originated
from ruptured ER membranes. Interestingly, the ability of amyloid fibrils to disrupt membranes
has also been previously observed by cryo-ET in vitro [81]. These observations with molecular
resolution guided the way to further analyses with fluorescence LM that supported these findings
and showed that the fibril–membrane interactions at IBs significantly disrupt the organization and
dynamics of the ER. Nuclear inclusions were indistinguishable from cytosolic ones in terms of
overall architecture, but did not contain any vesicles, nor did the fibrils contact the inner nuclear
membrane. By taking advantage of the latest advancements of cryo-ET, this study showed that fi-
bril–membrane interactions significantly disrupt both the organization and the dynamics of the ER,
thus pointing to a pathogenic role of IBs in HD [82].
Limitations of Cryo-ET
The optimal sample for the investigation of neurotoxic protein aggregates would be viable human
brain tissue from patients. Besides the challenges to retrieve living human brain tissue for this
purpose (which will be discussed in the next section), there are two main limitations that restrict
the sample size for cryo-ET analyses: vitrification and sample thinning.
Vitrification
Plunge freezing [83] is the most widely used vitrification method in cryo-ET to vitrify single cells. For
larger samples like tissue, high-pressure freezing [66] is often used, allowing vitrification for thick-
nesses up to a few 100 μm. Larger samples will form ice crystals in their core due to insufficient
cooling rates. This means that with current methods, only small tissue pieces (i.e., biopsies)
could potentially be vitrified, but not larger samples in their entirety.
Sample Thinning
One way of thinning samples is mechanical cryo-sectioning, which can produce thin sections
from cells and tissue. However, this method is associated with adverse artifacts, including strong
and irregular deformations of cellular structures [84–86]. Currently, cryo-FIB [71,87] has become
the gold standard to thin down vitrified cellular specimens. Although this works well for single cul-
tured cells, for much larger material like tissue, FIB-thinning is very time consuming and technically
challenging. Recently, the cryo-FIB technology has been extended to prepare lamellas from
tissue specimens: the lamella can be lifted out of the material, without the need to mill away
large sample volumes [88–90].
Concluding Remarks and Future Perspectives
In summary, twomethodological aspects are essential for the reliable investigation of the ultrastruc-
ture and the dynamics of neurotoxic protein aggregates: (i) imaging methods with high spatial and
temporal resolution; and (ii) sample preparation procedures that minimize disturbances of the
pathophysiological cellular situation and deliver reliable, reproducible, and unambiguous results.
Each method has its advantages and limitations. SR-LM has played an important role in the past
10 years in the investigation of the structural progression of protein aggregates in situ [54]. It is aTrends in Cell Biology, December 2020, Vol. 30, No. 12 961
Outstanding Questions
Can we use SR-LM and cryo-ET
synergistically to study the dynamics
and molecular architecture of protein
aggregates?
Can we adapt cryo-ET methodology to
enable examining patient-derived sam-
ples under close-to-native conditions?
Can an integrative multiscale imaging
approach contribute to the development
of new therapies for neurodegenerative
diseases?
Trends in Cell Biologyparticularly valuable method to analyze dynamic processes in living cells. However, SR methods
have two main limitations: they only allow visualization of fluorescently labeled structures but not
their local environment (but see [124]) and, secondly, the resolution is limited to 10–100 nm.
EM can achieve a resolution two orders of magnitude higher. Consequently, it can investigate the
ultrastructure of protein aggregates in situ. However, the sample preparation of conventional EM
suffers from harsh procedures that are very likely to induce structural alterations, particularly at the
molecular level. Thus, conventional EM is, in general, incompatible with high-resolution imaging of
biological specimens, which is reflected by the inconsistent observations of Htt IBs using this
method (Figure 1 and Table S1). By contrast, the sample preparation for cryo-ET is capable of
preserving the sample in a close-to-native state, making cryo-ET ideally suited for the ultrastruc-
tural investigation of biological specimens.
The recent advancements of cryo-ET enabled the direct visualization of the native ultrastructure of
IBs and their cellular interactions [61,91,125,126]. The major advantage of this method is the
three-dimensional representation of the cellular landscape at molecular resolution, depicting all
cellular structures, not only labeled components.
The controversial debate about the relevance of oligomers and IBs in neurodegenerative diseases
has not been resolved. However, the high-resolution imaging methods described in this review
have provided new insights to this debate beyond the known toxicity of oligomers. SR techniques
analyzed the dynamics of IBs and the aggregation process [12,57,58,60,62]. The evidence
derived from cryo-ET studies visualized for the first time the destructive potential of IBs [61,91].
Looking into the future, there are emerging technologies that may receive further attention in the
field (Box 3).Box 3. Emerging Methods
Cryo ptychographic X-ray computed tomography (cryo-PXCT) [119,120] is a method that uses synchrotron radiation to
visualize 3D subcellular features at a resolution of ~100 nm of specimens with a thickness approaching 100 μm. The
resolution is low in comparison with the techniques described earlier, yet the method has the advantage of allowing a
frozen-hydrated tissue sample (e.g., brain tissue from animal models or patients) to be imaged in its entirety without
labeling. Furthermore, after cryo-PXCT imaging, samplesmay potentially be further imaged by the high resolutionmethods
described in this review. This method could contribute insights into tissue-specific alterations (e.g., neuronal connectivity,
synaptic changes, and myelination).
In-cell nuclear magnetic resonance (in-cell NMR) can provide atomic resolution of intracellular protein structures and deliv-
ered valuable information about the cellular aggregation of α-synuclein [121]. The data of in-cell NMR reflects not a single-
cell analysis, but rather an ensemble-average of the population, where the signal originates from many molecules in many
cells.
Stimulated Raman scattering of selective deuterium labeling allows live-cell imaging and quantification of polyQ aggregates
[122]. Deuterated glutamine renders fluorescent labeling unnecessary. Miao et al. could measure absolute concentrations
of sequesteredmutant Htt and other proteins within the same aggregate and discovered that the percentage of mutant Htt
increases as the inclusion grows [122]. Since glutamine can cross the blood–brain barrier, an application of this method on
animal models and hypothetically on patients may be possible.
Correlative 3D super-resolution (SR) and scanning electron microscopy (SEM)-based imaging [123] is a method that combines
the strength of SR-LM in identifying proteins and the ability of SEM to visualize large cellular volumes. Cells are vitrified and im-
aged in 3D by SR methods (3D-SIM and SMACM) under cryo-conditions. Thereafter the frozen cells are dehydrated and em-
bedded in resin by freeze substitution and finally stained by heavy metals to increase contrast. In a dual-beam FIB-SEM
instrument, the focused ion-beam removes consecutively thin layers and so a large volume of the cell is imaged by the electron
beamwith an isotropic resolution of 4–8 nm. If thismethod is further developed to keep cells vitrified for the SEM-based imaging,
nonlinear deformation artifacts caused by freeze substitution could be avoided, however, probably with a forfeit in contrast.
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used to investigate the disease mechanisms. Valuable insights into neurodegenerative diseases
have been obtained from cell cultures and animal models. Nevertheless, after more than
110 years of research, there is not sufficient understanding of the pathomechanisms involved.
As a result, not a single pharmaceutical substance to date could modify the progression nor
the mortality of these diseases and pharmacological strategies are restricted to symptomatic
treatments. This implies that there is a large gap in knowledge of basic disease mechanisms.
To reach a comprehensive, pathophysiological understanding of neurodegenerative diseases,
it seems crucial to investigate the genuine disease situation. All cellular and animal models
recapitulate only partially the disease phenotypes [44,45]: for example, a single genetic mutation
is typically used to model the disease, while most patients do not have such mutations. The
pathogenic protein is overexpressed in model systems to observe aggregation in a reasonable
timeframe, contrary to patients that express this protein at normal level over decades. Model
systems do not exhibit the temporal speed of the disorder, nor the spectrum of pathologies and
symptoms, which challenges the translation of new findings from disease models to the clinic.
Thus, the future success of understanding these pathologies may depend on the investigation of
vital patient-derivedmaterial. However, postmortem tissue is not suitable for high-resolution stud-
ies, as brain tissue is extremely sensitive to anoxia and rapidly develops into brain death due to
global ischemia in the dying patient. Irreversible cerebral damage develops rapidly, leading to a
drastic decrease of survival in minutes if an individual is not resuscitated [92]. Furthermore, the
chance of a favorable neurological outcome of a surviving patient after 30 min of resuscitation
is vanishingly low [93], indicating major neuronal damage. Substantial structural alterations, af-
fecting most organelles and cytosolic structures, have been observed in the first minutes to
hours after global ischemia [94–97]. And importantly, cerebral ischemic injury and neurodegener-
ative disorders share many commonalities [94]. Thus, studies using high-resolution methods on
postmortem tissue [98,99] image a cellular situation in which the neurodegenerative pathologies
cannot be distinguished from postmortem artifacts and should thus be taken with caution.
This emphasizes the necessity of the vitality of patient-derived material: to be able to analyze
unaltered samples, they need to be collected from living patients. Brain biopsies are, due to
ethical considerations, restricted to therapeutic interventions (diagnostic biopsies, resection of
therapy refractory epilepsy). However, other tissues are more easily available and single cells of
these can be reprogrammed via induced pluripotent stem cells (iPSC) into neuronal cells [100].
However, iPSC-derived neurons failed to develop IBs in late-onset disorders [101], which may
be due to an epigenetic reset of the donor age [102]. Thus, further developments and new
strategies are necessary, as, for example, the direct conversion [103] that circumvents the epige-
netic resetting or the induced aging of iPSC-derived neurons [104–106].
In this review, we have presented and discussed novel high resolution methods with close-to-native
preparation methods that can be applied to patient-derived material. Combining these approaches
holds high potential for major breakthroughs in understanding neurodegenerative diseases and per-
haps may contribute to the development of effective treatments (see Outstanding Questions).Acknowledgments
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